CureVac N.V. (CVAC) Gain 54.19% YTD: Chances Are, Buyers Will Win the Tug-of-War
CureVac N.V. (NASDAQ:CVAC) shares fell to a low of $117.00 before closing at $125.00. Intraday shares traded counted 1.75 million, which was -75.14% lower than
CureVac N.V. (NASDAQ:CVAC) shares fell to a low of $117.00 before closing at $125.00. Intraday shares traded counted 1.75 million, which was -75.14% lower than
CureVac N.V. (NASDAQ:CVAC) shares fell to a low of $110.81 before closing at $111.48. Intraday shares traded counted 0.48 million, which was 53.55% higher than
CureVac N.V. (NASDAQ:CVAC) previous close was $115.67 while the outstanding shares total 177.97M. CVAC’s shares traded lower over the last trading session, losing -1.14% on
CureVac Receives COVID-19 vaccine development grant from the German Ministry as CVAC surged by double-digits on Friday. The pandemic vaccine development programs have pulled off
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne